pharma · Infertility · Ovarian Cancer · NWBO
NORTHWEST BIOTHERAPEUTICS
NORTHWEST BIOTHERAPEUTICS INC
NORTHWEST BIOTHERAPEUTICS clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
- Founded
- 1998
- Employees
- 20
- Programs
- 33
- Drugs
- 40
- Patents
- 595
NORTHWEST BIOTHERAPEUTICS projects
8 ClinicalTrials.gov programs sponsored by NORTHWEST BIOTHERAPEUTICS.
NORTHWEST BIOTHERAPEUTICS has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
DCVac-L
NORTHWEST BIOTHERAPEUTICS INC
Ovarian Cancer
1 trial -
DCVax-Direct
NORTHWEST BIOTHERAPEUTICS INC
Brain Metastases
1 trial -
Gonadotrophin releasing hormone agonist(GnRHa)
NORTHWEST BIOTHERAPEUTICS INC
GnRHa;LPS
1 trial -
Menopur 150 international units
NORTHWEST BIOTHERAPEUTICS INC
Pregnancy
1 trial -
Omega-3 fatty acids
NORTHWEST BIOTHERAPEUTICS INC
Metabolic Syndrome X
1 trial -
Xanthohumol
NORTHWEST BIOTHERAPEUTICS INC
Healthy
1 trial -
[14C]-benzo[a]pyrene
NORTHWEST BIOTHERAPEUTICS INC
Environmental Exposure
3 trials -
interceptive orthodontic treatments
NORTHWEST BIOTHERAPEUTICS INC
Malocclusion
1 trial
Frequently asked questions
How many clinical projects does NORTHWEST BIOTHERAPEUTICS have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.